Literature DB >> 2906641

Use of supplemented Stainer-Scholte broth for the isolation of Bordetella pertussis from clinical material.

C H von Koenig1, A Tacken, H Finger.   

Abstract

The use of Stainer-Scholte broth supplemented with (2,6-O-dimethyl)beta-cyclodextrin (heptakis) for the isolation of Bordetella pertussis from clinical specimens was evaluated with 3,632 nasal swabs from children and adults with suspected whooping cough or from their family contacts. The liquid enrichment medium was subcultured on charcoal agar with 10% defibrinated horse blood. Charcoal agar and soft charcoal agar served as the standard procedure to detect B. pertussis. We isolated 772 strains of B. pertussis (21%). Charcoal agar alone detected 87% of all strains (n = 668), soft charcoal agar grew 78% (n = 602), and 637 strains (83%) were isolated when Stainer-Scholte broth with heptakis was used. We detected 590 isolates with all three media. Whereas 65 strains grew only on charcoal agar, 27 strains were detected by soft charcoal agar. Supplemented Stainer-Scholte broth allowed the isolation of an additional 77 strains which did not primarily grow on charcoal media (P less than 0.05). Our data indicate that Stainer-Scholte medium supplemented with heptakis can be effectively used as an enrichment medium for detection of B. pertussis in clinical specimens.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2906641      PMCID: PMC266945          DOI: 10.1128/jcm.26.12.2558-2560.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  The growth of Bordetella pertussis: a review.

Authors:  E ROWATT
Journal:  J Gen Microbiol       Date:  1957-10

2.  Beef-heart charcoal agar for the preparation of pertussis vaccines.

Authors:  L MISHULOW; L S SHARPE; L L COHEN
Journal:  Am J Public Health Nations Health       Date:  1953-11

3.  Enrichment medium for the isolation of Bordetella.

Authors:  J Regan; F Lowe
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

4.  Selective medium for the isolation of bordetella pertussis and parapertussis.

Authors:  E M Sutcliffe; J D Abbott
Journal:  J Clin Pathol       Date:  1972-08       Impact factor: 3.411

5.  Symposium on pertussis immunization, in honor of Dr. Pearl L. Kendrick in her eightieth year: current diagnostic procedures in whooping cough.

Authors:  J Holwerda
Journal:  Health Lab Sci       Date:  1971-10

6.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

7.  Cephalexin-supplemented Jones-Kendrick charcoal agar for selective isolation of Bordetella pertussis: comparison with previously described media.

Authors:  L R Stauffer; D R Brown; R E Sandstrom
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

8.  Importance of culture in laboratory diagnosis of Bordetella pertussis infections.

Authors:  P H Gilligan; M C Fisher
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

9.  Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis.

Authors:  A Imaizumi; Y Suzuki; S Ono; H Sato; Y Sato
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Comparison of blood-free medium (cyclodextrin solid medium) with Bordet-Gengou medium for clinical isolation of Bordetella pertussis.

Authors:  T Aoyama; Y Murase; T Iwata; A Imaizumi; Y Suzuki; Y Sato
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

View more
  10 in total

Review 1.  Laboratory diagnosis of pertussis: state of the art in 1997.

Authors:  F M Müller; J E Hoppe; C H Wirsing von König
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Detection of Bordetella pertussis by determination of adenylate cyclase activity.

Authors:  C H Wirsing von Koenig; A Tacken; E L Hewlett
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

3.  O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.

Authors:  Xuqing Zhang; Maria Eugenia Rodríguez; Eric T Harvill
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

4.  Surface-associated filamentous hemagglutinin induces autoagglutination of Bordetella pertussis.

Authors:  F D Menozzi; P E Boucher; G Riveau; C Gantiez; C Locht
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

5.  The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis.

Authors:  Xuqing Zhang; Elizabeth M Goebel; Maria Eugenia Rodríguez; Andrew Preston; Eric T Harvill
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

6.  Role of pertussis toxin in causing symptoms of Bordetella parapertussis infection.

Authors:  C H Wirsing von König; H Finger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-06       Impact factor: 3.267

7.  Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection.

Authors:  Elizabeth M Goebel; Xuqing Zhang; Eric T Harvill
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

8.  Lack of cross-protection against Bordetella holmesii after pertussis vaccination.

Authors:  Xuqing Zhang; Laura S Weyrich; Jennie S Lavine; Alexia T Karanikas; Eric T Harvill
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

9.  Caspase-1-independent interleukin-1β is required for clearance of Bordetella pertussis infections and whole-cell vaccine-mediated immunity.

Authors:  David E Place; Sarah J Muse; Girish S Kirimanjeswara; Eric T Harvill
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

10.  Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture.

Authors:  Francisco Carriquiriborde; Pablo Martin Aispuro; Nicolás Ambrosis; Eugenia Zurita; Daniela Bottero; María Emilia Gaillard; Celina Castuma; Erika Rudi; Aníbal Lodeiro; Daniela F Hozbor
Journal:  Front Immunol       Date:  2021-09-15       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.